Operator Good afternoon, and welcome to the Sarepta Therapeutics fourth quarter and full year 2024 financial results ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced its financial results for the fourth quarter and full year ended December 31, 2024.

And welcome to the Sarepta Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call. As a reminder, today’s program is being recorded. At this time, I’d like to turn the call ...

More than two weeks after a helicopter and airplane collision over Washington killed 67 people, investigators have completed ...

Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...

Newcastle United chiefs at the Etihad Stadium had the perfect view of what CEO Darren Eales had spoken about as "the art of ...

Located near the cemetery is the Normandy Visitors Center, which highlights the D-Day timeline, the French resistance and many stories of the men and women who fought and contributed to the Allied ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 ...

As we welcome a new Friday (February 14) morning, the entertainment industry is already buzzing with many interesting and ...

Aoun has also insisted that Israel must adhere to the agreed-upon timeline. During his speech ... February 18, 2025 6:00 PM ...

09, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, will hold its first Ovarian Cancer R&D Day on ...